CClinicalTrials.gg
CompletedNCT01267981PREPINTESTUpdated Aug 7, 2024

Efficacy of Small Bowel Preparation in Capsule Endoscopy

A Phase 3 interventional study of Standard diet and Standard Diet + 500 ml of polyethyleneglycol in Gastrointestinal Bleedings, sponsored by University Hospital, Brest. Completed at 17 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-07.

Sponsored by University Hospital, Brest · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
858
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The best preparation of small bowel is still unknown. The primary aim of this study is to evaluate the polyethylene glycol (PEG) impact of small bowel preparation for unexplained gastrointestinal bleeding exploration. Three different preparations are evaluated in this study.

Read the detailed description

Now days, the endoscopic video-capsule is the more appropriate exam for unexplained gastrointestinal bleeding exploration. The responsible damage of this unexplained bleeding are frequently small vascular damages, hard to be detected in the bowel or ulcerations or tumors. The exam quality can be limited by food residues, bubbles or bile.

30% of damage are probably undetectable because of a lack of visibility. An efficient preparation will probably increased the quality of the video-capsule exploration.

The bowel exploration by endoscopy video-capsule will be realized in the usual condition. The study included 4 steps:

  1. Inclusion
  2. Randomization
  3. Video-capsule exploration
  4. Reading of the video-capsule exam by endoscopist doctors who are in blind.
02

Conditions studied

  • Gastrointestinal Bleedings

Keywords

  • Small bowel
  • video-capsule endoscopy
  • gastrointestinal bleeding
  • polyethylene glycol
03

In context

Gastrointestinal Hemorrhage

339 studies on the registry are indexed under Gastrointestinal Hemorrhage; 79 are open to participants now.

This study's enrollment of 858 is above the median of 87 across 211 interventional studies indexed under Gastrointestinal Hemorrhage.

Browse Gastrointestinal Hemorrhage studies →

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age >= 18 years old.
  • Patients who have an indication for video-capsule endoscopy exploration for unexplained gastrointestinal bleeding associated with anaemia (man : haemoglobin \<13 g/dl and woman haemoglobin \<12g/dl)
  • Less than one year Endoscopic assessment by colonoscopy and gastroscopy
  • Not participated to an another clinic study.
  • Written consent.

Exclusion criteria

Exclusion Criteria:

  • Age\<18 years old.
  • General physical health deterioration such as dehydration or cardiac insufficiency.
  • Clinical or radiological suspicion of digestive stenosis.
  • Oral iron taking in the 4 days before video-capsule exploration.
  • Functional or organic disorders of the gulp
  • Pregnant women.
  • Sensibility known about the polyethylene glycol.
  • No signed consent.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
858 participants (actual)

Study arms

  • Placebo comparator
    Preparation 1

    Standard diet: the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

    Drug: Standard diet

  • Active comparator
    Preparation 2

    Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water. 500 ml of polyethylene glycol 30 minutes after the ingestion of video-capsule endoscopy.

    Drug: Standard Diet + 500 ml of polyethyleneglycol

  • Active comparator
    Preparation 3

    Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water. 2 liters of polyethylene glycol between 7 pm and 9 pm. 500 ml of polyethylene glycol, 30 minutes after the ingestion of video-capsule endoscopy.

    Drug: Standard diet + 2 liters of polyethylene glycol the day before + 500ml of polyethylene glycol

Interventions

  • DrugStandard diet

    After the lunch the day before the exploration, drink only clear liquids and stop solid food. From 10 pm, stay fasting, don't drink except the usual drugs taken with mouthful of water until the exploration by video-capsule endoscopy.

  • DrugStandard Diet + 500 ml of polyethyleneglycol

    Apply the standard diet and drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

  • DrugStandard diet + 2 liters of polyethylene glycol the day before + 500ml of polyethylene glycol

    apply the standard diet and drink 2 liters of polyethylene glycol between 19h and 21h the day before exploration. Then drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

06

What researchers measure

Primary outcomes

  1. Compare the frequencies of the diagnoses of clinically significant lesions

    Compare the frequencies of the diagnoses of clinically significant lesions (P1 or P2)obtained with and without polyethylene glycol preparation for patients investigated by video-capsule endoscopy who have an unexplained digestive bleeding.

    Time frame: at the end of video-capsule exploration

Secondary outcomes

  1. The quality of the preparation and visibility of the bowel

    Demonstrate an improvement in preparation quality and bowel visibility in the various segments of small bowel examined by video-capsule endoscopy

    Time frame: at the end of video-capsule exploration

  2. The clinical tolerance

    Evaluate the clinical tolerance and the acceptability of the bowel preparation with oral polyethylene glycol solution

    Time frame: 8 days after video-capsule exploration

  3. The number of all the observed lesions

    Estimate the number of all the observed lesions on the recording according to their hemorrhagic potential.

    Time frame: at the end of video-capsule exploration

  4. Compare different times

    Compare gastric emptying time, the bowel transit time and the percentage complete medical exploration of small bowel for every group of patients (ileo- cecal valve exceeded).

    Time frame: at the end of video-capsule exploration

  5. Crossing (yes or no) of ileo-cecal valve by the EVC

    Time frame: At the end of video-capsule exploration

07

Study locations

17 sites
  • Centre Hospitalier d'Avignon
    Avignon, 84000, France
  • Cabinet privé
    Beziers, France
  • Centre Hospitalier d'Avicenne
    Bobigny, 93000, France
  • CHOLET
    Brest, 29200, France
  • CHRU de Lille
    Lille, 59037, France
  • Saint Philibert Hospital
    Lomme, 59160, France
  • CH Bretagne Sud
    Lorient, 56100, France
  • Edouard Herriot Hospital
    Lyon, 69437, France
  • Hôpital de La Conception
    Marseille, 13274, France
  • Hôpital de la Timone
    Marseille, 13385, France
  • Centre Hospitalier Universitaire de Nice
    Nice, 06202, France
  • Hôpital Cochin
    Paris, 75014, France
  • Höpital Européen Geores Pompidou
    Paris, 75015, France
  • CH de Cornouaille Quimper
    Quimper, 29000, France
  • Centre Hospitalier de Saint Brieuc
    Saint Brieuc, 22000, France
  • Hôpital Privé de L'Est Lyonnais
    Saint Priest, 69800, France
  • CH Bretagne Atlantique
    Vannes, 56017, France
08

References and documents

Publications

  • Rahmi G, Cholet F, Gaudric M, Filippi J, Duburque C, Bramli S, Quentin V, Alavi Z, Nowak E, Saurin JC, Cellier C, Queneherve L; PREPINTEST working group. Effect of Different Modalities of Purgative Preparation on the Diagnostic Yield of Small Bowel Capsule for the Exploration of Suspected Small Bowel Bleeding: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2022 Feb 1;117(2):327-335. doi: 10.14309/ajg.0000000000001597. PubMed 35041627 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01267981
Lead sponsor
University Hospital, Brest
Collaborators
Ministry of Health, France
Responsible party
Sponsor
First posted
Dec 29, 2010
Start date
Sep 2010
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Aug 7, 2024

Study contacts

Franck CHOLET, MD
principal investigator · CHRU Brest

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion